July 29, 2021
Immunomic Therapeutics Expands Board of Directors with Appointments of Two New Members – Immunomic Therapeutics
ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study…
